Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip Janku

Showing results (91-100 of 277) with videos related to

Pageof 28
Sort By:
Molecular Cancer Therapeutics|April 25, 2019
Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell HistiocytosisFilip Janku, Eli L Diamond, Aaron M Goodman, et al.
Plos One|June 8, 2012
KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitorsIgnacio Garrido-Laguna, David S Hong, Filip Janku, et al.
Oncotarget|December 17, 2017
Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patientsOwen T M Chan, Hideki Furuya, Ian Pagano, et al.
Oncotarget|June 15, 2013
Thymoma patients treated in a phase I clinic at MD Anderson Cancer Center: responses to mTOR inhibitors and molecular analysesJennifer Wheler, David Hong, Stephen G Swisher, et al.
Journal for Immunotherapy of Cancer|January 11, 2021
Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II studyNazanin Majd, Steven G Waguespack, Filip Janku, et al.
Investigational New Drugs|December 6, 2013
Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignanciesSiqing Fu, Ming-Mo Hou, Jennifer Wheler, et al.
Scientific Reports|October 5, 2021
A novel method for liquid-phase extraction of cell-free DNA for detection of circulating tumor DNAFilip Janku, Helen J Huang, David Y Pereira, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2018
A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvementElena Fountzilas, Elangovan Krishnan, Filip Janku, et al.
Investigational New Drugs|March 31, 2015
Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancerDavid S Hong, Filip Janku, Aung Naing, et al.
Blood Advances|March 1, 2023
Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysisAshley Aaroe, Razelle Kurzrock, Gaurav Goyal, et al.
Pageof 28

Showing results (91-100 of 277) with videos related to

Sort By:
Pageof 28
Molecular Cancer Therapeutics|April 25, 2019
Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell HistiocytosisFilip Janku, Eli L Diamond, Aaron M Goodman, et al.
Plos One|June 8, 2012
KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitorsIgnacio Garrido-Laguna, David S Hong, Filip Janku, et al.
Oncotarget|December 17, 2017
Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patientsOwen T M Chan, Hideki Furuya, Ian Pagano, et al.
Oncotarget|June 15, 2013
Thymoma patients treated in a phase I clinic at MD Anderson Cancer Center: responses to mTOR inhibitors and molecular analysesJennifer Wheler, David Hong, Stephen G Swisher, et al.
Journal for Immunotherapy of Cancer|January 11, 2021
Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II studyNazanin Majd, Steven G Waguespack, Filip Janku, et al.
Investigational New Drugs|December 6, 2013
Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignanciesSiqing Fu, Ming-Mo Hou, Jennifer Wheler, et al.
Scientific Reports|October 5, 2021
A novel method for liquid-phase extraction of cell-free DNA for detection of circulating tumor DNAFilip Janku, Helen J Huang, David Y Pereira, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2018
A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvementElena Fountzilas, Elangovan Krishnan, Filip Janku, et al.
Investigational New Drugs|March 31, 2015
Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancerDavid S Hong, Filip Janku, Aung Naing, et al.
Blood Advances|March 1, 2023
Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysisAshley Aaroe, Razelle Kurzrock, Gaurav Goyal, et al.
Pageof 28